• strict warning: Declaration of views_handler_filter_node_status::operator_form() should be compatible with views_handler_filter::operator_form(&$form, &$form_state) in /home/nwrageadmin/ on line 13.
  • strict warning: Declaration of views_plugin_style_default::options() should be compatible with views_object::options() in /home/nwrageadmin/ on line 24.

Ventria Biopharm Rice: Anheuser-Busch drops Threat to Boycott Missouri Rice


Anheuser-Busch drops Threat to Boycott Missouri Rice

Saturday, April 16, 2005

WASHINGTON (AP) -- Anheuser-Busch Cos. has dropped its threat to boycott
Missouri's rice crop after a biotechnology firm agreed to grow its genetically engineered rice farther away from commercial rice farms in the state.

Missouri: Riceland, Anheuser-Busch against Bootheel Pharma-rice


Apr 11, 2005 8:02 AM

By David Bennett

Plans remain on schedule for some 150 acres of Ventria Bioscience genetically modified rice to be planted in the Missouri Bootheel. The rice, which contains human genes, has many farmers and environmental groups concerned. They fear it will contaminate nearby food-grade rice and thus ruin markets. Ventria, meanwhile, said the worries are overblown and the rice will provide cheaper medicines.

Now, add Riceland Foods and Anheuser Busch to those opposing the pharmaceutical rice. In late March, both companies released letters stating such.

Oregon Senate Considers 'Biopharm' Crops Ban


Senate Considers 'Biopharm' Crops Ban

SOURCE: Associated Press, by Niki Sullivan / Corvallis Gazette-Times, USA
9 Apr 2005

Lawmakers mull temporary halt to growing biologically engineered foodstuffs

Can Pharmaceutical Rice be Contained?


Can Pharmaceutical Rice be Contained?

Mar 31, 2005 By David Bennett Delta Farm Press

Pharm Corn: Biotech Request Alarms food Industry


Biotech Request Alarms food Industry

The Grocery Manufacturers of America is concerned about ProdiGene's plans to grow biotech corn in Texas.

August 6, 2004

Washington, D.C. - A biotech company is seeking federal approval to begin regular production of pharmaceutical corn crops, a move that has alarmed the U.S. food industry.

Syndicate content